Commentary on: Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data from the Phase 3 REFINE Trials

Jeffrey M. Kenkel, Nicholas Lahar

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Commentary on: Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data from the Phase 3 REFINE Trials'. Together they form a unique fingerprint.